ANI PHARMACEUTICALS INC (ANIP) has 122 open-market insider trades by 28 insiders since 2013. Over the last six months insiders net sold $5.9M. The most active filer is Tracy Marshbanks, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Meridian Venture Partners II L.P. | 10% Owner | — | 5 | $40.7M | 2023-08-16 |
| Muthusamy Shanmugam | COO | — | 4 | $39.0M | 2026-02-26 |
| Tracy Marshbanks | Dir | — | 9 | $37.7M | 2018-05-16 |
| Nikhil Lalwani | CEOPres | — | 7 | $32.8M | 2026-10-15 |
| Daniel Raynor | Dir | — | 6 | $17.8M | 2018-03-19 |
| Arthur Przybyl | CEOPres | — | 7 | $15.1M | 2020-04-07 |
| Arthur Przybyl | CEOPres | — | 7 | $12.8M | 2020-04-07 |
| Meridian Venture Partners II GP, L.P. | Dir10% Owner | — | 2 | $9.8M | 2022-12-01 |
| Stephen P. Carey | CFOVP | — | 6 | $8.8M | 2026-09-29 |
| James G. Marken | VP | — | 9 | $8.6M | 2024-06-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Nikhil Lalwani | CEO & President | Sell | $388K | 2026-10-15 |
| Meredith Cook | CLO & VP +1 | Sell | $37K | 2026-10-13 |
| Stephen P. Carey | CFO & VP | Sell | $208K | 2026-09-29 |
| Nikhil Lalwani | CEO & President | Sell | $383K | 2026-09-15 |
| Meredith Cook | CLO & VP +1 | Sell | $35K | 2026-09-14 |
| Jeanne Thoma | Director | Sell | $72K |
Companies that share insiders with ANIP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-09-11 |
| Stephen P. Carey | CFO & VP | Sell | $207K | 2026-08-31 |
| Nikhil Lalwani | CEO & President | Sell | $401K | 2026-08-25 |
| Meredith Cook | CLO & VP +1 | Sell | $38K | 2026-08-13 |
| Ori Gutwerg | VP | Sell | $243K | 2026-08-10 |
| Stephen P. Carey | CFO & VP | Sell | $232K | 2026-07-29 |
| Meredith Cook | CLO & VP +1 | Sell | $41K | 2026-07-13 |
| Stephen P. Carey | CFO & VP | Sell | $285K | 2026-07-02 |
| Stephen P. Carey | CFO & VP | Sell | $240K | 2026-06-29 |
| Meredith Cook | CLO & VP +1 | Sell | $41K | 2026-06-12 |